Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control.
- Mikhael F. El-ChamiF. Al-Samadi P. Roberts
- 1 December 2018
Medicine
Atrioventricular synchronous pacing using a leadless ventricular pacemaker: Results from the MARVEL 2 study.
- C. SteinwenderS. Khelae L. Chinitz
- 2 November 2019
Medicine, Engineering
Heart Failure and Atrial Fibrillation, Like Fire and Fury.
- M. CarlisleM. FudimA. DeVoreJ. Piccini
- 1 June 2019
Medicine
Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
- Eric Black-MaierXinru Ren J. Piccini
- 1 December 2017
Medicine
Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.
- Allen WangJennifer B. GreenJ. HalperinJ. Piccini
- 1 August 2019
Medicine
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of…
- S. TzeisE. Gerstenfeld S. Trines
- 30 March 2024
Medicine
This consensus is a joint effort from collaborating cardiac electrophysiology societies, namely the European Heart Rhythm Association, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society.
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker
- J. PicciniRyan Cunnane L. Mont
- 13 January 2022
Medicine
The overall rate of pericardial effusion following Micra implantation attempt is 1.1% and has decreased over time and can be predicted using pre-procedural clinical characteristics with reasonable discrimination.
Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator: A Meta-Analysis.
- A. PandeyAkhil Parashar J. Berry
- 1 February 2017
Medicine
Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up
- Mikhael F. El-ChamiL. Bockstedt J. Piccini
- 11 November 2021
Medicine
In a real-world study of US Medicare patients, the Micra leadless VVI pacemaker was associated with a 38% loweradjusted rate of reinterventions and a 31% lower adjusted rate of chronic complications compared with transvenous VVI pacing.
Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19
It is hypothesize that a cholinergic anti-inflammatory pathway could be _targeted as a therapeutic avenue in COVID-19 and that patients with the highest rate of morbidity and mortality following SARS-CoV2 infection have also developed a hyperinflammatory syndrome.
...
...